Amondina, Sheryl .

HRN: 09-16-60  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2025
AMPICILLIN 1GM (VIAL)
03/31/2025
04/07/2025
IV
2g
Q6hrs
PROM - Thinly
Waiting Final Action 
04/01/2025
CEFUROXIME 500MG (TAB)
04/01/2025
04/08/2025
ORAL
500mg
BID
Sp NSVD; UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: